Immunology Investor Event slide image

Immunology Investor Event

Dupixent: Chronic Pruritis of Unknown Origin Prevalence(1) Treated Number of patients (thousands) Biologic eligible 133 Source: Sanofi analysis (1) 18+ population 16 Immunology Investor Event 259 466 Treated with systemic therapy 0 50 100 150 200 250 300 350 400 450 500 US sanofi
View entire presentation